Market Access Specialty Pharmacy Accreditation: DCI’s Exclusive Analysis Reveals a Market at an Inflection Point Drug ChannelsThe Drug Channels Institute (DCI) team attended Asembia's AXS26 Summit last week.Read full story pharminent May 5, 2026 (Last updated: May 5, 2026) Drug Channels The Drug Channels Institute (DCI) team attended Asembia’s AXS26 Summit last week. Read full story Post navigation Previous: Lannett, Lanexa Biologics and Sunshine Lake secure FDA approval for LanglaraNext: Cytokinetics heart drug scores in closely watched trial Related Stories Market Access How cost and perception could reshape the GLP-1 market pharminent August 21, 2026 Market Access D.C. Circuit Affirms HHS Authority Over 340B Rebate Models pharminent July 24, 2026 Market Access NICE aims to cut funding for Amgen lung cancer drug Lumykras pharminent July 9, 2026
